Vimarsana
Biggest News Aggregation in the World

Page 6 - Guy Goodwin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Guy Goodwin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Guy Goodwin Today - Breaking & Trending Today

Magic mushrooms compound 'effective at treating depression in cancer patients' - Vimarsana News

Magic mushrooms compound 'effective at treating depression in cancer patients'

Largest ever trial of psilocybin offers hope of treatment to cancer patients with major depressive disorder

Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study - Vimarsana News

Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study

The research conducted at Cedar Clinical Research in Draper is part of the first ever phase 3 program of psilocybin therapy, and the largest of its kind VANCOUVER, BC, May 30, 2023 /PRNewswire/ -... | May 30, 2023

Numinus Wellness Inc announces largest-of-its-kind Phase 3 study of psilocybin therapy to treat depression - Vimarsana News

Numinus Wellness Inc announces largest-of-its-kind Phase 3 study of psilocybin therapy to treat depression

Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) said its wholly-owned subsidiary Cedar Clinical Research (CCR) has begun studying COMP360 psilocybin therapy, an...

Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023 - Vimarsana News

Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023

More than half of the patients demonstrated remission of depression at 18 months, after a single dose of 25mg investigational COMP360 psilocybin with psychological supportOpen label phase 2 study,... | May 26, 2023

COMPASS Pathways: Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023 - Vimarsana News

COMPASS Pathways: Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023

More than half of the patients demonstrated remission of depression at 18 months, after a single dose of 25mg investigational COMP360 psilocybin with psychological supportOpen label phase 2 study, conducted